| All figures in €'000 | Notes | 2016 | 2015* |
| Revenue | (8) | 590,559 | 535,651 |
| Other revenue | (9) | 19,810 | 18,667 |
| Total revenue | 610,369 | 554,318 | |
| Commission expenses | (10) | -298,505 | -253,584 |
| Interest expenses | (11) | -1,711 | -1,921 |
| Loan loss provisions | -1,619 | 156 | |
| Personnel expenses | (12) | -121,847 | -113,457 |
| Depreciation and impairment | (13) | -23,962 | -15,113 |
| Other operating expenses | (14) | -145,137 | -141,528 |
| Earnings from investments accounted for using the equity method | (15) | 2,106 | 1,836 |
| Earnings before interest and tax (EBIT) | 19,694 | 30,706 | |
| Other interest and similar income | 906 | 509 | |
| Other interest and similar expenses | -1,851 | -3,263 | |
| Finance cost | (16) | -946 | -2,753 |
| Earnings before tax (EBT) | 18,748 | 27,953 | |
| Income taxes | (17) | -4,052 | -8,170 |
| Net profit | 14,696 | 19,783 | |
| Of which attributable to | |||
| owners of the parent company | 14,696 | 19,783 | |
| Earnings per share in € | (18) | ||
| basic/diluted | 0.13 | 0.18 | |
| All figures in €'000 | Notes | 2016 | 2015 |
| Net profit | 14,696 | 19,783 | |
| Gains/losses due to the revaluation of defined benefit obligations | (28) | -5,387 | 2,489 |
| Deferred taxes on non-reclassifiable gains/losses | (17) | 1,602 | -727 |
| Non-reclassifiable gains/losses | -3,784 | 1,762 | |
| Gains/losses from changes in the fair value of available-for-sale securities | (24) | 140 | -339 |
| Deferred taxes on reclassifiable gains/losses | (17) | -100 | 91 |
| Reclassifiable gains/losses | 40 | -248 | |
| Other comprehensive income | -3,744 | 1,514 | |
| Total comprehensive income | 10,952 | 21,297 | |
| Of which attributable to | |||
| owners of the parent company | 10,952 | 21,297 | |
